RHENMAN & PARTNERS ASSET MANAGEMENT AB – Revance Therapeutics, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$8.65M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.78% | -62K shares | 2.43M | $27 | 388K |
| Q2 2022 | share | Increase | +126.86% | 251.64K shares | 2.35M | $13.82 | 450K |
| Q1 2022 | share | Increase | 0.00% | 198.35K shares | 3.86M | $19.5 | 198.35K |
| Q4 2021 | share | Decrease | -100.00% | -320K shares | -8.91M | $16.49 | 0 |
| Q3 2021 | share | Increase | +18.52% | 50K shares | 912K | $27.86 | 320K |
| Q2 2021 | share | Increase | +22.73% | 50K shares | 1.85M | $29.64 | 270K |
| Q1 2021 | share | 0.00% | 0 shares | -86K | $27.95 | 220K | |
| Q4 2020 | share | 0.00% | 0 shares | 704K | $28.34 | 220K | |
| Q3 2020 | share | 0.00% | 0 shares | 159K | $25.14 | 220K | |
| Q2 2020 | share | 0.00% | 0 shares | 2.11M | $24.42 | 220K | |
| Q1 2020 | share | Decrease | -12.00% | -30K shares | -802K | $14.8 | 220K |
| Q4 2019 | share | Increase | +43.75% | 76.08K shares | 1.79M | $16.23 | 250K |
| Q3 2019 | share | Decrease | -9.97% | -19.26K shares | -245K | $13 | 173.91K |
| Q2 2019 | share | 0.00% | 0 shares | -539K | $12.97 | 193.18K | |
| Q1 2019 | share | 0.00% | 0 shares | -844K | $15.76 | 193.18K | |
| Q4 2018 | share | Decrease | -4.92% | -10K shares | -1.16M | $20.13 | 193.18K |
| Q3 2018 | share | 0.00% | 0 shares | -528K | $24.85 | 203.18K | |
| Q2 2018 | share | 0.00% | 0 shares | -681K | $27.45 | 203.18K | |
| Q1 2018 | share | Increase | +11.28% | 20.60K shares | -269K | $30.8 | 203.18K |
| Q4 2017 | share | Decrease | -25.90% | -63.82K shares | -261K | $35.75 | 182.58K |
| Q3 2017 | share | Increase | +12.00% | 26.4K shares | 980K | $27.55 | 246.4K |
| Q2 2017 | share | Increase | +4.76% | 10K shares | 1.44M | $26.4 | 220K |
| Q1 2017 | share | 0.00% | 0 shares | 21K | $20.8 | 210K | |
| Q4 2016 | share | 0.00% | 0 shares | 942.9K | $20.7 | 210K | |
| Q3 2016 | share | Decrease | -4.55% | -10K shares | 412.1K | $16.21 | 210K |
| Q2 2016 | share | Increase | +29.41% | 50K shares | 24K | $13.6 | 220K |
| Q1 2016 | share | Decrease | -1.73% | -3K shares | -2.94M | $17.46 | 170K |